Officially guilty: GSK fined $486m for Chinese bribery
This article was originally published in Scrip
Executive Summary
In a humiliating end to GlaxoSmithKline's Chinese bribery scandal, the UK major has been fined a record sum of around $486m (£297m) after it was officially found guilty of bribery by the Changsha Intermediate People's Court in Hunan Province.